Skip to main content
Premium Trial:

Request an Annual Quote

After Management Buyout, MRC s Genome Service Will Continue Commercially as Geneservice

NEW YORK, June 6 (GenomeWeb News) - Following a management buyout, MRC Geneservice, a provider of genomics reagents and services funded by the UK's Medical Research Council, will on Aug. 1 re-emerge as a commercial company called Geneservice, Cambridge, UK-based MRC Geneservice said today.

 

The new company will take over the assets and most of the staff of government-funded MRC Geneservice and will be based in the CambridgeSciencePark.

 

Geneservice will continue to archive and distribute genomic reagents, such as bacterial clones and human DNA samples generated by academic groups and consortia, and provide genomic services, such as DNA sequencing, genotyping, microarray expression analysis, and genome amplification.

 

In addition, the company plans to invest in new business opportunities, including resources such as RNAi and protein expression libraries.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.